Kevin Khin-Zaw Lee, MD
Pulmonary Disease · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A73871 · Current
Licensed to practise in California · since 2001 · expires 2028-05-31 · Institute of Medicine (I) Rangoon.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$278,584
Medicare paid this office $278,584 for 1,057 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 421 | $71,603 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $49,065 | $104 |
| Short return visit (20+ min) | 292 | $32,521 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 135 | $26,591 | $69 |
| Critical care, first 30-74 minutes | 71 | $24,432 | $184 |
See all 18 services
| Return visit (30+ min) | 421 | $71,603 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $49,065 | $104 |
| Short return visit (20+ min) | 292 | $32,521 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 135 | $26,591 | $69 |
| Critical care, first 30-74 minutes | 71 | $24,432 | $184 |
| New patient visit (45+ min) | 135 | $17,881 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $13,644 | $153 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 492 | $9,792 | $15 |
| Sleep study including heart rate, breathing, and sleep time | 67 | $6,276 | $92 |
| Aspiration of fluid from chest cavity using imaging guidance | 26 | $3,305 | $92 |
| Test to examine how well the lungs exchange gases | 72 | $2,794 | $38 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 17 | $2,534 | $141 |
| Test to determine lung volumes using sensors | 64 | $2,532 | $39 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 65 | $1,869 | $28 |
| Sleep study in sleep lab (6 years or older) | 15 | $1,566 | $104 |
| Test to determine lung volumes using sensors | 123 | $1,243 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 121 | $1,065 | $9 |
| Test to examine how well the lungs exchange gases | 125 | $934 | $7 |
Who their Medicare patients are
1,057 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 16% · Women 52% · Also on Medicaid 24% · Health risk score 1.91. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Chronic kidney disease 43% · COPD 38% · Coronary heart disease 37% · Diabetes 35% · Atrial fibrillation 30% · Heart failure 29% · Depression 24% · Cancer 20% · Stroke 14% · Dementia 12%.
The office billed $1,679,231, Medicare allowed $366,787 and paid $278,584; for 3,758 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,057 | 3,758 | 76 | 1.91 | $1,679,231 | $278,584 |
| 2023 | 709 | 2,155 | 75 | 1.92 | $1,244,391 | $237,969 |
| 2022 | 733 | 2,440 | 75 | 1.89 | $1,444,366 | $262,371 |
| 2021 | 701 | 2,575 | 75 | 2.11 | $1,562,117 | $298,976 |
| 2020 | 720 | 2,983 | 75 | 2.45 | $1,783,228 | $301,902 |
| 2019 | 779 | 3,398 | 75 | 2.44 | $1,880,059 | $323,701 |
| 2018 | 672 | 3,518 | 76 | 2.25 | $1,643,068 | $341,622 |
| 2017 | 634 | 3,787 | 76 | 2.29 | $1,503,552 | $326,311 |
| 2016 | 628 | 3,923 | 76 | 2.35 | $940,141 | $335,345 |
| 2015 | 669 | 4,172 | 76 | 2.40 | $906,295 | $350,701 |
| 2014 | 684 | 4,069 | 76 | 2.29 | $850,385 | $344,822 |
| 2013 | 730 | 4,867 | 76 | 2.20 | $929,274 | $378,031 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Return visit (30+ min) | 248 | $42,059 | $114 |
| Critical care, first 30-74 minutes | 84 | $36,498 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $35,253 | $105 |
| Short return visit (20+ min) | 208 | $24,187 | $76 |
| New patient visit (45+ min) | 154 | $21,936 | $142 |
| Sleep study in sleep lab (6 years or older) | 29 | $18,481 | $637 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 27 | $17,993 | $666 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 76 | $14,416 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $8,340 | $154 |
| Sleep study including heart rate, breathing, and sleep time | 29 | $4,477 | $154 |
| Aspiration of fluid from chest cavity using imaging guidance | 18 | $2,367 | $95 |
| Critical care, each additional 30 minutes | 13 | $1,393 | $93 |
| Test to determine lung volumes using sensors | 93 | $977 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 86 | $774 | $9 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 17 | $773 | $45 |
| Test to examine how well the lungs exchange gases | 93 | $721 | $8 |
2022: 23 services
| Critical care, first 30-74 minutes | 134 | $63,455 | $187 |
| Return visit (30+ min) | 262 | $50,819 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 129 | $36,161 | $92 |
| Short return visit (20+ min) | 173 | $18,947 | $75 |
| New patient visit (45+ min) | 111 | $16,559 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 95 | $14,123 | $64 |
| Sleep study in sleep lab (6 years or older) | 24 | $13,034 | $543 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 20 | $12,653 | $633 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,862 | $167 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 12 | $3,348 | $279 |
| Aspiration of fluid from chest cavity using imaging guidance | 17 | $2,501 | $96 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,485 | $155 |
| Critical care, each additional 30 minutes | 20 | $2,186 | $95 |
| Influenza vaccine split virus, preservative free | 22 | $1,505 | $68 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 15 | $1,080 | $67 |
| Sleep study including heart rate, breathing, airflow, and effort | 13 | $977 | $75 |
| Test to determine lung volumes using sensors | 92 | $953 | $10 |
| Administration of influenza virus vaccine | 24 | $866 | $36 |
| Administration of pneumococcal vaccine | 20 | $725 | $36 |
| Test to examine how well the lungs exchange gases | 92 | $704 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 78 | $701 | $9 |
| Ultrasonic guidance for blood vessel access | 12 | $150 | $12 |
| Test to measure expiratory airflow and volume | 16 | $109 | $7 |
2021: 24 services
| Critical care, first 30-74 minutes | 152 | $76,533 | $193 |
| Return visit (30+ min) | 246 | $55,415 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 149 | $46,302 | $96 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 32 | $20,190 | $631 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 112 | $18,918 | $66 |
| New patient visit (45+ min) | 107 | $18,007 | $168 |
| Short return visit (20+ min) | 142 | $16,836 | $76 |
| Sleep study in sleep lab (6 years or older) | 19 | $10,814 | $569 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,721 | $184 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $3,342 | $159 |
| Critical care, each additional 30 minutes | 24 | $3,078 | $99 |
| Long return visit (40+ min) | 12 | $2,423 | $173 |
| Influenza vaccine split virus, preservative free | 28 | $1,884 | $65 |
| Pneumococcal vaccine, 23-valent | 14 | $1,751 | $125 |
| Aspiration of fluid from chest cavity using imaging guidance | 13 | $1,401 | $100 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 11 | $1,367 | $124 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 12 | $1,049 | $75 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 18 | $993 | $52 |
| Test to determine lung volumes using sensors | 65 | $697 | $11 |
| Administration of influenza virus vaccine | 29 | $636 | $21 |
| Test to examine how well the lungs exchange gases | 69 | $548 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 54 | $502 | $9 |
| Administration of pneumococcal vaccine | 14 | $297 | $21 |
| Test to measure expiratory airflow and volume | 20 | $144 | $7 |
2020: 24 services
| Critical care, first 30-74 minutes | 171 | $100,820 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 182 | $51,835 | $96 |
| Return visit (30+ min) | 197 | $35,809 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 179 | $34,570 | $66 |
| Short return visit (20+ min) | 176 | $17,944 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $12,356 | $177 |
| New patient visit (30+ min) | 72 | $6,603 | $92 |
| Critical care, each additional 30 minutes | 39 | $4,812 | $100 |
| Long return visit (40+ min) | 33 | $4,508 | $125 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 25 | $2,880 | $115 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $2,421 | $105 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,964 | $140 |
| Influenza vaccine split virus, preservative free | 29 | $1,762 | $61 |
| Pneumococcal vaccine, 23-valent | 12 | $1,439 | $120 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 17 | $1,402 | $74 |
| Aspiration of fluid from chest cavity using imaging guidance | 11 | $1,235 | $103 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 13 | $948 | $68 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $879 | $52 |
| Administration of influenza virus vaccine | 30 | $617 | $21 |
| Test to determine lung volumes using sensors | 32 | $355 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 28 | $328 | $12 |
| Administration of pneumococcal vaccine | 16 | $328 | $20 |
| Test to examine how well the lungs exchange gases | 34 | $280 | $8 |
| Ultrasonic guidance for blood vessel access | 19 | $276 | $13 |
2019: 30 services
| Critical care, first 30-74 minutes | 151 | $83,130 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 218 | $61,332 | $93 |
| Return visit (30+ min) | 234 | $45,571 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 205 | $30,997 | $65 |
| Short return visit (20+ min) | 185 | $20,003 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $15,230 | $177 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 14 | $8,672 | $619 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 39 | $5,446 | $140 |
| New patient visit (45+ min) | 36 | $5,439 | $151 |
| New patient visit (30+ min) | 43 | $4,223 | $98 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 19 | $3,674 | $61 |
| Long return visit (40+ min) | 22 | $3,295 | $137 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 26 | $3,104 | $115 |
| Influenza vaccine split virus, preservative free | 50 | $2,742 | $55 |
| Pneumococcal vaccine, 23-valent | 22 | $2,437 | $111 |
| Critical care, each additional 30 minutes | 22 | $2,370 | $99 |
| Aspiration of fluid from chest cavity using imaging guidance | 18 | $2,183 | $104 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,407 | $67 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 18 | $1,362 | $72 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $1,179 | $69 |
| Administration of influenza virus vaccine | 52 | $1,049 | $20 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $817 | $51 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 56 | $667 | $12 |
| Test to determine lung volumes using sensors | 59 | $661 | $11 |
| Administration of pneumococcal vaccine | 29 | $585 | $20 |
| Test to examine how well the lungs exchange gases | 59 | $489 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 31 | $407 | $13 |
| Test to determine lung volumes using sensors | 32 | $392 | $12 |
| Test to examine how well the lungs exchange gases | 32 | $306 | $10 |
| Ultrasonic guidance for blood vessel access | 19 | $254 | $13 |
2018: 25 services
| Critical care, first 30-74 minutes | 156 | $72,106 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 188 | $58,838 | $90 |
| Return visit (30+ min) | 227 | $47,311 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 192 | $35,555 | $63 |
| Short return visit (20+ min) | 154 | $18,601 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $17,462 | $175 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 27 | $17,097 | $611 |
| Pneumococcal vaccine, 13-valent | 36 | $7,200 | $200 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $6,306 | $134 |
| Pneumococcal vaccine, 23-valent | 48 | $5,068 | $106 |
| New patient visit (45+ min) | 36 | $4,733 | $131 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 21 | $4,466 | $60 |
| Long return visit (40+ min) | 31 | $3,976 | $117 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 53 | $3,133 | $59 |
| Influenza vaccine split virus, preservative free | 58 | $3,121 | $52 |
| Test to determine lung volumes using sensors | 57 | $3,052 | $54 |
| Test to examine how well the lungs exchange gases | 56 | $3,002 | $54 |
| Hospital discharge day management, more than 30 minutes | 26 | $2,935 | $95 |
| New patient visit (30+ min) | 29 | $2,773 | $96 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 18 | $2,256 | $103 |
| Administration of pneumococcal vaccine | 84 | $2,124 | $25 |
| Administration of influenza virus vaccine | 61 | $1,593 | $25 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 17 | $1,536 | $85 |
| Hospital discharge day management, 30 minutes or less | 15 | $962 | $64 |
| Ultrasonic guidance for blood vessel access | 15 | $210 | $12 |
2017: 24 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 209 | $79,614 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 172 | $67,931 | $63 |
| Return visit (30+ min) | 226 | $53,224 | $92 |
| Critical care, first 30-74 minutes | 120 | $49,167 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $13,035 | $176 |
| Short return visit (20+ min) | 96 | $9,657 | $62 |
| New patient visit (45+ min) | 57 | $8,046 | $141 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 42 | $5,640 | $134 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 22 | $4,694 | $204 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 11 | $4,133 | $62 |
| Long return visit (40+ min) | 27 | $3,793 | $122 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,392 | $96 |
| Influenza vaccine split virus, preservative free | 48 | $2,348 | $48 |
| Critical care, each additional 30 minutes | 17 | $1,829 | $96 |
| Initial hospital observation care per day, typically 70 minutes | 11 | $1,790 | $163 |
| Administration of influenza virus vaccine | 56 | $1,773 | $31 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 16 | $1,661 | $104 |
| Hospital discharge day management, 30 minutes or less | 15 | $1,033 | $65 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 11 | $977 | $89 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 61 | $698 | $11 |
| Test to determine lung volumes using sensors | 61 | $656 | $11 |
| Test to examine how well the lungs exchange gases | 61 | $485 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $223 | $12 |
| Ultrasonic guidance for blood vessel access | 17 | $213 | $13 |
2016: 27 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 223 | $83,503 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 245 | $68,634 | $62 |
| Critical care, first 30-74 minutes | 108 | $49,758 | $189 |
| Return visit (30+ min) | 178 | $33,016 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 153 | $29,833 | $173 |
| Short return visit (20+ min) | 116 | $13,271 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 70 | $9,013 | $129 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 35 | $8,233 | $61 |
| Pneumococcal vaccine, 13-valent | 34 | $6,048 | $173 |
| New patient visit (45+ min) | 33 | $4,418 | $134 |
| Hospital discharge day management, more than 30 minutes | 33 | $3,646 | $93 |
| Long return visit (40+ min) | 20 | $2,413 | $115 |
| Initial hospital observation care per day, typically 70 minutes | 14 | $2,231 | $159 |
| Influenza vaccine split virus, preservative free | 56 | $2,192 | $38 |
| Administration of influenza virus vaccine | 59 | $1,825 | $30 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 15 | $1,750 | $103 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,454 | $63 |
| Administration of pneumococcal vaccine | 34 | $1,047 | $30 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $778 | $46 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 27 | $293 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $290 | $13 |
| Test to determine lung volumes using sensors | 26 | $266 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $264 | $18 |
| Ultrasonic guidance for blood vessel access | 15 | $198 | $12 |
| Test to examine how well the lungs exchange gases | 26 | $196 | $8 |
| Test to determine lung volumes using sensors | 14 | $190 | $14 |
| Test to examine how well the lungs exchange gases | 14 | $156 | $11 |
2015: 25 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 232 | $87,073 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 306 | $76,526 | $62 |
| Return visit (30+ min) | 198 | $37,760 | $91 |
| Critical care, first 30-74 minutes | 86 | $34,988 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 162 | $31,237 | $175 |
| Pneumococcal vaccine, 13-valent | 77 | $13,279 | $168 |
| Short return visit (20+ min) | 121 | $12,954 | $59 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 41 | $10,314 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 62 | $8,171 | $132 |
| New patient visit (45+ min) | 47 | $6,201 | $132 |
| Hospital discharge day management, more than 30 minutes | 36 | $3,476 | $94 |
| Administration of pneumococcal vaccine | 79 | $2,432 | $30 |
| Influenza vaccine split virus, preservative free | 62 | $2,207 | $36 |
| Long return visit (40+ min) | 15 | $2,064 | $121 |
| Hospital discharge day management, 30 minutes or less | 28 | $1,978 | $64 |
| Administration of influenza virus vaccine | 64 | $1,922 | $30 |
| Initial hospital observation care per day, typically 70 minutes | 11 | $1,921 | $160 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 12 | $1,444 | $103 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 17 | $1,069 | $46 |
| Follow-up observation care per day, typically 25 minutes | 12 | $815 | $63 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 32 | $364 | $11 |
| Test to determine lung volumes using sensors | 32 | $343 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $265 | $13 |
| Test to examine how well the lungs exchange gases | 32 | $254 | $8 |
| Ultrasonic guidance for blood vessel access | 12 | $175 | $13 |
2014: 27 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 265 | $103,319 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 277 | $66,980 | $62 |
| Return visit (30+ min) | 210 | $38,510 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 179 | $34,903 | $173 |
| Critical care, first 30-74 minutes | 73 | $33,824 | $189 |
| Short return visit (20+ min) | 106 | $11,213 | $62 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 37 | $8,564 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 58 | $7,465 | $129 |
| New patient visit (45+ min) | 26 | $3,671 | $141 |
| Hospital discharge day management, more than 30 minutes | 31 | $3,535 | $93 |
| Initial hospital observation care per day, typically 70 minutes | 15 | $2,384 | $159 |
| Hospital discharge day management, 30 minutes or less | 30 | $2,144 | $63 |
| Critical care, each additional 30 minutes | 17 | $2,084 | $95 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 17 | $1,865 | $104 |
| Long return visit (40+ min) | 13 | $1,789 | $128 |
| Influenza vaccine split virus, preservative free | 53 | $1,726 | $33 |
| Administration of influenza virus vaccine | 57 | $1,698 | $30 |
| New patient visit (30+ min) | 16 | $1,516 | $95 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 11 | $1,408 | $74 |
| Follow-up observation care per day, typically 25 minutes | 15 | $1,187 | $62 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 22 | $1,105 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $381 | $15 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 29 | $329 | $11 |
| Administration of pneumococcal vaccine | 11 | $328 | $30 |
| Test to determine lung volumes using sensors | 29 | $310 | $11 |
| Ultrasonic guidance for blood vessel access | 17 | $232 | $13 |
| Test to examine how well the lungs exchange gases | 29 | $229 | $8 |
2013: 26 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 271 | $105,957 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 370 | $99,734 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 206 | $39,687 | $167 |
| Return visit (30+ min) | 201 | $37,555 | $90 |
| Critical care, first 30-74 minutes | 64 | $25,276 | $183 |
| Short return visit (20+ min) | 142 | $14,912 | $57 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 48 | $11,418 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $5,620 | $128 |
| Hospital discharge day management, 30 minutes or less | 54 | $4,079 | $62 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 21 | $3,992 | $190 |
| Administration of influenza virus vaccine | 89 | $2,738 | $30 |
| Initial hospital observation care per day, typically 70 minutes | 19 | $2,715 | $143 |
| New patient visit (45+ min) | 14 | $2,025 | $145 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,735 | $91 |
| Influenza vaccine split virus, preservative free | 53 | $1,645 | $31 |
| New patient visit (30+ min) | 18 | $1,627 | $90 |
| Critical care, each additional 30 minutes | 16 | $1,580 | $93 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 21 | $1,253 | $48 |
| Follow-up observation care per day, typically 25 minutes | 12 | $954 | $60 |
| Hospital observation care on day of discharge | 13 | $801 | $62 |
| Nursing facility discharge day management, 30 minutes or less | 11 | $682 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $472 | $15 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 38 | $449 | $12 |
| Test to determine lung volumes using sensors | 26 | $291 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 26 | $290 | $11 |
| Test to examine how well the lungs exchange gases | 24 | $197 | $8 |
Medicaid work
$16,763 in 2024
Medicaid paid $16,763 for 522 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 329 | $8,923 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 160 | $5,107 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 33 | $2,733 |
| 2024 | 522 | 3 | 25 | $16,763 |
| 2023 | 519 | 6 | 22 | $17,090 |
| 2022 | 307 | 2 | 19 | $9,938 |
| 2021 | 699 | 3 | 30 | $27,220 |
| 2020 | 430 | 3 | 25 | $13,205 |
| 2019 | 126 | 2 | 14 | $5,736 |
| 2018 | 263 | 2 | 17 | $6,455 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 310 | $10,209 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 134 | $3,664 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 36 | $3,126 |
| EVALUATION OF WHEEZING | 13 | $37 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 13 | $32 |
| Diffusing capacity | 13 | $23 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 164 | $5,384 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 143 | $4,554 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 105 | $9,228 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 309 | $9,151 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 285 | $8,841 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 180 | $6,368 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 222 | $4,856 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 28 | $1,981 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 34 | $2,948 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 92 | $2,788 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 177 | $4,041 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 86 | $2,415 |
Drugs they prescribed that Part D paid
$1,069,817
Pharmacies billed $1,069,817 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,360) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
619 generic and 741 brand-name prescriptions · $1,069,817 in drug cost · 73 antibiotic prescriptions to 38 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 31 | $387,745 | $12,508 |
| Trelegy Ellipta | 157 | $211,366 | $1,346 |
| Spiriva Respimat | 54 | $72,633 | $1,345 |
| Breo Ellipta | 81 | $68,517 | $846 |
| Xolair | 14 | $48,726 | $3,480 |
See all 26 drugs
| Ofev | 31 | $387,745 | $12,508 |
| Trelegy Ellipta | 157 | $211,366 | $1,346 |
| Spiriva Respimat | 54 | $72,633 | $1,345 |
| Breo Ellipta | 81 | $68,517 | $846 |
| Xolair | 14 | $48,726 | $3,480 |
| Arnuity Ellipta | 85 | $38,285 | $450 |
| Stiolto Respimat | 18 | $23,402 | $1,300 |
| Symbicort | 42 | $17,159 | $409 |
| Advair Hfa | 12 | $7,505 | $625 |
| Breyna | 14 | $5,736 | $410 |
| Albuterol Sulfate Hfa | 193 | $5,521 | $29 |
| Pulmicort Flexhaler | 11 | $5,353 | $487 |
| Wixela Inhub | 22 | $3,830 | $174 |
| Fluticasone-Salmeterol | 24 | $3,587 | $149 |
| Roflumilast | 23 | $3,078 | $134 |
| Ventolin Hfa | 28 | $2,833 | $101 |
| Montelukast | 148 | $2,663 | $18 |
| Azelastine | 32 | $1,601 | $50 |
| Prednisone | 51 | $418 | $8 |
| Ipratropium | 15 | $392 | $26 |
| Mirtazapine | 16 | $359 | $22 |
| Cefdinir | 19 | $291 | $15 |
| Doxycycline Hyclate | 17 | $141 | $8 |
| Trazodone | 28 | $116 | $4 |
| Zolpidem | 15 | $94 | $6 |
| Azithromycin | 20 | $63 | $3 |
Year by year
| 2024 | 1,360 | 284 | 0% (0) | 54% | $1,069,817 |
| 2023 | 1,105 | 230 | None | 56% | $727,171 |
| 2022 | 1,575 | 232 | 2% (31) | None | $703,595 |
| 2021 | 1,890 | 219 | 2% (33) | None | $669,911 |
| 2020 | 2,370 | 217 | 1% (28) | None | $621,382 |
| 2019 | 2,820 | 256 | 1% (38) | None | $606,176 |
| 2018 | 3,225 | 269 | 2% (75) | None | $543,380 |
| 2017 | 3,297 | 300 | 3% (92) | None | $484,149 |
| 2016 | 4,021 | 331 | 3% (118) | None | $455,437 |
| 2015 | 3,535 | 299 | 3% (93) | None | $317,772 |
| 2014 | 3,394 | 262 | 3% (110) | None | $286,828 |
| 2013 | 3,144 | 247 | 4% (112) | None | $261,702 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Trelegy Ellipta | 72 | $109,418 | $1,520 |
| Breo Ellipta | 97 | $88,678 | $914 |
| Xolair | 26 | $80,884 | $3,111 |
| Spiriva Respimat | 45 | $53,937 | $1,199 |
| Symbicort | 57 | $45,629 | $801 |
| Stiolto Respimat | 22 | $31,560 | $1,435 |
| Arnuity Ellipta | 38 | $20,057 | $528 |
| Flovent Hfa | 32 | $13,631 | $426 |
| Advair Diskus | 12 | $9,055 | $755 |
| Pulmicort Flexhaler | 13 | $5,598 | $431 |
| Ventolin Hfa | 36 | $2,945 | $82 |
| Albuterol Sulfate Hfa | 95 | $2,918 | $31 |
| Montelukast | 138 | $2,846 | $21 |
| Azelastine | 17 | $1,123 | $66 |
| Modafinil | 11 | $552 | $50 |
| Atorvastatin | 14 | $265 | $19 |
| Pantoprazole | 11 | $223 | $20 |
| Trazodone | 16 | $175 | $11 |
| Prednisone | 28 | $156 | $6 |
| Azithromycin | 16 | $98 | $6 |
| Doxycycline Hyclate | 11 | $94 | $9 |
2022: 38 drugs
| Trelegy Ellipta | 61 | $108,204 | $1,774 |
| Breo Ellipta | 85 | $80,256 | $944 |
| Xolair | 24 | $70,795 | $2,950 |
| Spiriva Respimat | 54 | $53,459 | $990 |
| Symbicort | 58 | $44,983 | $776 |
| Stiolto Respimat | 23 | $30,238 | $1,315 |
| Eliquis | 19 | $25,769 | $1,356 |
| Daliresp | 13 | $12,814 | $986 |
| Jardiance | 12 | $12,231 | $1,019 |
| Flovent Hfa | 25 | $12,146 | $486 |
| Incruse Ellipta | 14 | $11,133 | $795 |
| Arnuity Ellipta | 20 | $9,258 | $463 |
| Pulmicort Flexhaler | 14 | $7,781 | $556 |
| Albuterol Sulfate Hfa | 103 | $4,308 | $42 |
| Montelukast | 157 | $3,305 | $21 |
| Ventolin Hfa | 30 | $1,923 | $64 |
| Prevalite | 13 | $1,353 | $104 |
| Atorvastatin | 60 | $1,162 | $19 |
| Azelastine | 13 | $784 | $60 |
| Dextroamphetamine-Amphetamine | 12 | $590 | $49 |
| Metformin | 29 | $492 | $17 |
| Metoprolol | 16 | $393 | $25 |
| Levothyroxine | 23 | $393 | $17 |
| Amlodipine Besylate | 36 | $393 | $11 |
| Trazodone | 16 | $318 | $20 |
| Pantoprazole | 16 | $238 | $15 |
| Modafinil | 11 | $235 | $21 |
| Cefdinir | 17 | $230 | $14 |
| Alendronate | 17 | $223 | $13 |
| Losartan | 22 | $215 | $10 |
| Lisinopril | 14 | $178 | $13 |
| Doxycycline Hyclate | 14 | $152 | $11 |
| Prednisone | 30 | $151 | $5 |
| Gabapentin | 16 | $141 | $9 |
| Hydrocodone-Acetaminophen | 13 | $132 | $10 |
| Lorazepam | 11 | $118 | $11 |
| Azithromycin | 21 | $116 | $6 |
| Tramadol | 12 | $25 | $2 |
2021: 50 drugs
| Breo Ellipta | 86 | $72,767 | $846 |
| Spiriva Respimat | 56 | $64,162 | $1,146 |
| Trelegy Ellipta | 43 | $61,612 | $1,433 |
| Xolair | 18 | $55,463 | $3,081 |
| Symbicort | 69 | $49,273 | $714 |
| Eliquis | 30 | $25,214 | $840 |
| Jardiance | 14 | $22,890 | $1,635 |
| Stiolto Respimat | 14 | $19,391 | $1,385 |
| Spiriva | 12 | $14,198 | $1,183 |
| Xarelto | 18 | $13,943 | $775 |
| Flovent Hfa | 13 | $9,620 | $740 |
| Pulmicort Flexhaler | 17 | $8,354 | $491 |
| Albuterol Sulfate Hfa | 69 | $3,766 | $55 |
| Ventolin Hfa | 43 | $3,078 | $72 |
| Montelukast | 132 | $3,059 | $23 |
| Prevalite | 24 | $2,421 | $101 |
| Atorvastatin | 97 | $2,016 | $21 |
| Olmesartan Medoxomil | 13 | $1,640 | $126 |
| Proair Hfa | 12 | $1,204 | $100 |
| Metoprolol | 37 | $886 | $24 |
| Oxybutynin Chloride Er | 17 | $734 | $43 |
| Levothyroxine | 46 | $685 | $15 |
| Azelastine | 11 | $658 | $60 |
| Amlodipine Besylate | 45 | $561 | $12 |
| Metformin | 47 | $489 | $10 |
| Omeprazole | 16 | $474 | $30 |
| Alendronate | 23 | $471 | $20 |
| Losartan | 33 | $410 | $12 |
| Pantoprazole | 19 | $398 | $21 |
| Gabapentin | 25 | $345 | $14 |
| Lisinopril | 24 | $323 | $13 |
| Tamsulosin | 13 | $314 | $24 |
| Triamterene-Hydrochlorothiazid | 16 | $304 | $19 |
| Fluticasone Propionate | 13 | $300 | $23 |
| Sertraline | 18 | $276 | $15 |
| Cefdinir | 11 | $269 | $24 |
| Hydrocodone-Acetaminophen | 12 | $232 | $19 |
| Prednisone | 29 | $214 | $7 |
| Zolpidem | 13 | $207 | $16 |
| Lovastatin | 14 | $196 | $14 |
| Fluoxetine | 12 | $177 | $15 |
| Donepezil | 15 | $175 | $12 |
| Azithromycin | 16 | $143 | $9 |
| Simvastatin | 19 | $126 | $7 |
| Metoprolol | 16 | $119 | $7 |
| Furosemide | 14 | $112 | $8 |
| Rosuvastatin | 11 | $107 | $10 |
| Atenolol | 16 | $94 | $6 |
| Lorazepam | 20 | $60 | $3 |
| Tramadol | 13 | $56 | $4 |
2020: 57 drugs
| Xolair | 22 | $62,004 | $2,818 |
| Symbicort | 84 | $57,586 | $686 |
| Breo Ellipta | 75 | $54,546 | $727 |
| Spiriva Respimat | 46 | $45,876 | $997 |
| Trelegy Ellipta | 31 | $33,930 | $1,095 |
| Eliquis | 47 | $28,431 | $605 |
| Stiolto Respimat | 28 | $24,446 | $873 |
| Flovent Hfa | 39 | $22,992 | $590 |
| Spiriva | 15 | $16,615 | $1,108 |
| Xarelto | 28 | $15,867 | $567 |
| Advair Diskus | 20 | $14,499 | $725 |
| Jardiance | 15 | $13,476 | $898 |
| Pulmicort Flexhaler | 13 | $7,363 | $566 |
| Budesonide | 15 | $3,799 | $253 |
| Ventolin Hfa | 44 | $2,837 | $64 |
| Albuterol Sulfate Hfa | 56 | $2,836 | $51 |
| Montelukast | 138 | $2,831 | $21 |
| Memantine Hcl Er | 11 | $2,730 | $248 |
| Prevalite | 19 | $2,579 | $136 |
| Proair Hfa | 19 | $2,041 | $107 |
| Atorvastatin | 108 | $1,539 | $14 |
| Levothyroxine | 67 | $1,515 | $23 |
| Oxybutynin Chloride Er | 19 | $987 | $52 |
| Metoprolol | 37 | $937 | $25 |
| Diltiazem 24hr Er (Cd) | 13 | $905 | $70 |
| Losartan | 53 | $846 | $16 |
| Tamsulosin | 38 | $837 | $22 |
| Potassium Chloride | 28 | $812 | $29 |
| Pantoprazole | 34 | $561 | $16 |
| Amlodipine Besylate | 59 | $535 | $9 |
| Fenofibrate | 12 | $533 | $44 |
| Metformin | 61 | $498 | $8 |
| Omeprazole | 24 | $413 | $17 |
| Lisinopril | 39 | $410 | $11 |
| Gabapentin | 22 | $380 | $17 |
| Alendronate | 28 | $351 | $13 |
| Fluticasone Propionate | 19 | $332 | $17 |
| Triamterene-Hydrochlorothiazid | 22 | $305 | $14 |
| Doxycycline Hyclate | 21 | $284 | $14 |
| Pravastatin | 11 | $281 | $26 |
| Ipratropium-Albuterol | 20 | $266 | $13 |
| Lovastatin | 15 | $255 | $17 |
| Sertraline | 26 | $255 | $10 |
| Escitalopram | 12 | $248 | $21 |
| Donepezil | 20 | $247 | $12 |
| Prednisone | 44 | $222 | $5 |
| Allopurinol | 18 | $221 | $12 |
| Hydrocodone-Acetaminophen | 14 | $196 | $14 |
| Simvastatin | 27 | $195 | $7 |
| Atenolol | 21 | $193 | $9 |
| Furosemide | 39 | $163 | $4 |
| Zolpidem | 27 | $161 | $6 |
| Metoprolol | 17 | $130 | $8 |
| Azithromycin | 16 | $115 | $7 |
| Lorazepam | 28 | $109 | $4 |
| Fluoxetine | 14 | $99 | $7 |
| Hydrochlorothiazide | 18 | $67 | $4 |
2019: 70 drugs
| Xolair | 24 | $65,817 | $2,742 |
| Symbicort | 102 | $64,304 | $630 |
| Breo Ellipta | 60 | $43,434 | $724 |
| Trelegy Ellipta | 33 | $36,086 | $1,094 |
| Spiriva Respimat | 46 | $35,425 | $770 |
| Stiolto Respimat | 38 | $30,617 | $806 |
| Xarelto | 40 | $21,893 | $547 |
| Flovent Hfa | 42 | $18,909 | $450 |
| Eliquis | 30 | $17,435 | $581 |
| Spiriva | 13 | $16,542 | $1,272 |
| Januvia | 11 | $12,409 | $1,128 |
| Combivent Respimat | 12 | $12,166 | $1,014 |
| Namenda Xr | 12 | $5,698 | $475 |
| Arnuity Ellipta | 13 | $5,046 | $388 |
| Budesonide | 18 | $4,559 | $253 |
| Memantine Hcl Er | 16 | $4,037 | $252 |
| Ventolin Hfa | 68 | $3,951 | $58 |
| Potassium Chloride | 36 | $2,177 | $60 |
| Montelukast | 117 | $1,979 | $17 |
| Levothyroxine | 105 | $1,816 | $17 |
| Albuterol Sulfate Hfa | 27 | $1,660 | $61 |
| Atorvastatin | 125 | $1,657 | $13 |
| Proair Hfa | 16 | $1,555 | $97 |
| Prevalite | 13 | $1,494 | $115 |
| Olmesartan Medoxomil | 24 | $1,472 | $61 |
| Metoprolol | 30 | $1,357 | $45 |
| Fenofibrate | 14 | $927 | $66 |
| Losartan | 75 | $843 | $11 |
| Lisinopril | 84 | $827 | $10 |
| Gabapentin | 33 | $786 | $24 |
| Sertraline | 48 | $685 | $14 |
| Omeprazole | 30 | $677 | $23 |
| Doxycycline Hyclate | 26 | $607 | $23 |
| Tamsulosin | 28 | $599 | $21 |
| Metformin | 69 | $570 | $8 |
| Pravastatin | 20 | $567 | $28 |
| Hydrocodone-Acetaminophen | 19 | $517 | $27 |
| Cefuroxime | 23 | $505 | $22 |
| Lovastatin | 35 | $494 | $14 |
| Pantoprazole | 45 | $493 | $11 |
| Lamotrigine | 14 | $477 | $34 |
| Finasteride | 16 | $465 | $29 |
| Isosorbide Mononitrate Er | 16 | $448 | $28 |
| Diltiazem 24hr Er (Cd) | 15 | $434 | $29 |
| Verapamil Er | 13 | $408 | $31 |
| Fluticasone Propionate | 27 | $398 | $15 |
| Allopurinol | 24 | $384 | $16 |
| Alendronate | 35 | $358 | $10 |
| Zolpidem | 38 | $358 | $9 |
| Ipratropium-Albuterol | 21 | $338 | $16 |
| Amlodipine Besylate | 64 | $338 | $5 |
| Prednisone | 60 | $318 | $5 |
| Mirtazapine | 13 | $285 | $22 |
| Famotidine | 22 | $280 | $13 |
| Escitalopram | 12 | $271 | $23 |
| Donepezil | 21 | $268 | $13 |
| Furosemide | 57 | $253 | $4 |
| Clopidogrel | 18 | $252 | $14 |
| Atenolol | 29 | $239 | $8 |
| Simvastatin | 27 | $224 | $8 |
| Metoprolol | 26 | $186 | $7 |
| Lorazepam | 37 | $177 | $5 |
| Metformin Hcl Er | 16 | $163 | $10 |
| Methylprednisolone | 12 | $146 | $12 |
| Azithromycin | 20 | $127 | $6 |
| Citalopram Hbr | 17 | $111 | $7 |
| Hydrochlorothiazide | 28 | $97 | $3 |
| Fluoxetine | 17 | $96 | $6 |
| Clonidine | 12 | $49 | $4 |
| Acetaminophen-Codeine | 11 | $19 | $2 |
2018: 84 drugs
| Ofev | 12 | $114,266 | $9,522 |
| Symbicort | 104 | $47,777 | $459 |
| Spiriva Respimat | 46 | $34,241 | $744 |
| Breo Ellipta | 39 | $28,933 | $742 |
| Stiolto Respimat | 40 | $28,382 | $710 |
| Spiriva | 26 | $25,304 | $973 |
| Advair Diskus | 20 | $23,619 | $1,181 |
| Flovent Hfa | 42 | $21,632 | $515 |
| Eliquis | 29 | $15,154 | $523 |
| Xarelto | 41 | $11,927 | $291 |
| Combivent Respimat | 19 | $8,734 | $460 |
| Trelegy Ellipta | 12 | $8,546 | $712 |
| Incruse Ellipta | 12 | $8,437 | $703 |
| Namenda Xr | 14 | $6,064 | $433 |
| Bevespi Aerosphere | 13 | $5,517 | $424 |
| Pulmicort Flexhaler | 11 | $5,135 | $467 |
| Dulera | 13 | $5,042 | $388 |
| Memantine Hcl Er | 14 | $4,917 | $351 |
| Budesonide | 19 | $4,678 | $246 |
| Proair Hfa | 57 | $4,646 | $82 |
| Ventolin Hfa | 73 | $4,392 | $60 |
| Novolog | 11 | $3,332 | $303 |
| Potassium Chloride | 35 | $2,903 | $83 |
| Alphagan P | 14 | $2,216 | $158 |
| Levothyroxine | 126 | $2,151 | $17 |
| Montelukast | 90 | $1,962 | $22 |
| Atorvastatin | 126 | $1,863 | $15 |
| Celecoxib | 17 | $1,347 | $79 |
| Metoprolol | 29 | $1,236 | $43 |
| Prevalite | 11 | $1,223 | $111 |
| Pravastatin | 24 | $1,199 | $50 |
| Boostrix Tdap | 18 | $1,126 | $63 |
| Oxybutynin Chloride Er | 20 | $1,124 | $56 |
| Tamsulosin | 52 | $1,020 | $20 |
| Gabapentin | 55 | $1,008 | $18 |
| Losartan | 99 | $851 | $9 |
| Megestrol Acetate | 11 | $799 | $73 |
| Metformin | 86 | $786 | $9 |
| Proair Respiclick | 11 | $673 | $61 |
| Lisinopril | 76 | $668 | $9 |
| Verapamil Er | 13 | $664 | $51 |
| Fenofibrate | 12 | $642 | $54 |
| Sertraline | 48 | $639 | $13 |
| Finasteride | 25 | $595 | $24 |
| Diltiazem 24hr Er (Cd) | 12 | $585 | $49 |
| Lamotrigine | 16 | $551 | $34 |
| Lovastatin | 41 | $511 | $12 |
| Pantoprazole | 35 | $490 | $14 |
| Omeprazole | 32 | $482 | $15 |
| Hydrocodone-Acetaminophen | 27 | $476 | $18 |
| Doxycycline Hyclate | 22 | $458 | $21 |
| Fluticasone Propionate | 29 | $450 | $16 |
| Oxycodone-Acetaminophen | 16 | $427 | $27 |
| Allopurinol | 28 | $406 | $14 |
| Simvastatin | 42 | $371 | $9 |
| Donepezil | 42 | $368 | $9 |
| Ipratropium-Albuterol | 23 | $335 | $15 |
| Amlodipine Besylate | 71 | $334 | $5 |
| Mirtazapine | 17 | $325 | $19 |
| Famotidine | 25 | $287 | $11 |
| Azithromycin | 36 | $286 | $8 |
| Methylprednisolone | 25 | $282 | $11 |
| Alendronate | 38 | $274 | $7 |
| Furosemide | 64 | $273 | $4 |
| Cefuroxime | 13 | $270 | $21 |
| Pilocarpine | 11 | $268 | $24 |
| Atenolol | 30 | $258 | $9 |
| Amitriptyline | 14 | $240 | $17 |
| Metoprolol | 32 | $210 | $7 |
| Pioglitazone | 11 | $205 | $19 |
| Prednisone | 44 | $190 | $4 |
| Clopidogrel | 15 | $186 | $12 |
| Lorazepam | 37 | $182 | $5 |
| Zolpidem | 37 | $154 | $4 |
| Escitalopram | 16 | $140 | $9 |
| Trazodone | 13 | $139 | $11 |
| Levofloxacin | 20 | $134 | $7 |
| Hydrochlorothiazide | 27 | $119 | $4 |
| Carvedilol | 13 | $112 | $9 |
| Dicyclomine | 11 | $105 | $10 |
| Citalopram Hbr | 14 | $103 | $7 |
| Fluoxetine | 15 | $100 | $7 |
| Methadone | 11 | $67 | $6 |
| Alprazolam | 22 | $60 | $3 |
2017: 84 drugs
| Ofev | 14 | $125,533 | $8,967 |
| Spiriva Respimat | 66 | $39,827 | $603 |
| Symbicort | 79 | $34,614 | $438 |
| Stiolto Respimat | 36 | $25,801 | $717 |
| Advair Diskus | 35 | $24,688 | $705 |
| Breo Ellipta | 47 | $20,489 | $436 |
| Xarelto | 51 | $19,982 | $392 |
| Namenda Xr | 30 | $16,039 | $535 |
| Spiriva | 23 | $15,447 | $672 |
| Eliquis | 22 | $11,143 | $507 |
| Budesonide | 23 | $5,843 | $254 |
| Flovent Hfa | 20 | $5,811 | $291 |
| Invokamet | 12 | $5,290 | $441 |
| Dulera | 16 | $4,618 | $289 |
| Proair Hfa | 49 | $4,523 | $92 |
| Incruse Ellipta | 12 | $3,935 | $328 |
| Vesicare | 11 | $3,471 | $316 |
| Levothyroxine | 150 | $2,695 | $18 |
| Ventolin Hfa | 42 | $2,445 | $58 |
| Atorvastatin | 133 | $2,126 | $16 |
| Celecoxib | 13 | $2,001 | $154 |
| Metoprolol | 42 | $1,904 | $45 |
| Alphagan P | 13 | $1,884 | $145 |
| Montelukast | 79 | $1,501 | $19 |
| Prevalite | 12 | $1,338 | $112 |
| Pravastatin | 33 | $1,325 | $40 |
| Gabapentin | 57 | $1,278 | $22 |
| Tamsulosin | 50 | $1,158 | $23 |
| Losartan | 100 | $944 | $9 |
| Ursodiol | 12 | $833 | $69 |
| Omeprazole | 43 | $821 | $19 |
| Metformin | 91 | $778 | $9 |
| Lisinopril | 83 | $734 | $9 |
| Potassium Chloride | 25 | $710 | $28 |
| Fenofibrate | 12 | $650 | $54 |
| Ipratropium-Albuterol | 25 | $648 | $26 |
| Allopurinol | 38 | $615 | $16 |
| Oxybutynin Chloride Er | 13 | $600 | $46 |
| Finasteride | 38 | $579 | $15 |
| Sertraline | 53 | $533 | $10 |
| Donepezil | 54 | $509 | $9 |
| Isosorbide Mononitrate Er | 19 | $503 | $26 |
| Simvastatin | 57 | $497 | $9 |
| Lamotrigine | 16 | $489 | $31 |
| Fluticasone Propionate | 27 | $477 | $18 |
| Furosemide | 101 | $470 | $5 |
| Verapamil Er | 11 | $464 | $42 |
| Ondansetron | 11 | $445 | $40 |
| Lorazepam | 45 | $442 | $10 |
| Lovastatin | 32 | $435 | $14 |
| Doxycycline Hyclate | 24 | $418 | $17 |
| Hydrocodone-Acetaminophen | 45 | $381 | $8 |
| Zolpidem | 47 | $365 | $8 |
| Quetiapine | 14 | $363 | $26 |
| Amlodipine Besylate | 57 | $358 | $6 |
| Alendronate | 42 | $350 | $8 |
| Oxycodone-Acetaminophen | 12 | $318 | $27 |
| Polyethylene Glycol 3350 | 11 | $314 | $29 |
| Cefuroxime | 16 | $292 | $18 |
| Famotidine | 30 | $278 | $9 |
| Pantoprazole | 25 | $273 | $11 |
| Metoprolol | 37 | $263 | $7 |
| Triamterene-Hydrochlorothiazid | 14 | $261 | $19 |
| Atenolol | 35 | $258 | $7 |
| Prednisone | 37 | $252 | $7 |
| Clopidogrel | 16 | $248 | $15 |
| Carvedilol | 32 | $244 | $8 |
| Mirtazapine | 16 | $237 | $15 |
| Klor-Con 10 | 12 | $197 | $16 |
| Losartan-Hydrochlorothiazide | 11 | $194 | $18 |
| Trazodone | 15 | $161 | $11 |
| Levofloxacin | 21 | $146 | $7 |
| Tramadol | 13 | $135 | $10 |
| Cephalexin | 14 | $127 | $9 |
| Alprazolam | 24 | $121 | $5 |
| Citalopram Hbr | 14 | $116 | $8 |
| Glipizide | 11 | $110 | $10 |
| Amitriptyline | 13 | $110 | $8 |
| Diltiazem 24hr Er | 11 | $71 | $6 |
| Methadone | 11 | $67 | $6 |
| Ciprofloxacin | 13 | $66 | $5 |
| Fluoxetine | 16 | $61 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $42 | $4 |
| Dicyclomine | 11 | $37 | $3 |
2016: 84 drugs
| Symbicort | 83 | $37,622 | $453 |
| Spiriva Respimat | 47 | $29,597 | $630 |
| Advair Diskus | 44 | $24,211 | $550 |
| Spiriva | 36 | $21,586 | $600 |
| Namenda Xr | 59 | $19,847 | $336 |
| Stiolto Respimat | 30 | $18,916 | $631 |
| Breo Ellipta | 31 | $17,969 | $580 |
| Xarelto | 42 | $12,884 | $307 |
| Sensipar | 11 | $8,481 | $771 |
| Dulera | 23 | $6,919 | $301 |
| Budesonide | 23 | $6,357 | $276 |
| Azilect | 18 | $5,484 | $305 |
| Benicar | 15 | $5,044 | $336 |
| Flovent Hfa | 15 | $4,751 | $317 |
| Levemir | 16 | $4,568 | $286 |
| Proair Hfa | 60 | $4,302 | $72 |
| Valsartan | 43 | $3,789 | $88 |
| Levothyroxine | 171 | $3,393 | $20 |
| Vesicare | 11 | $3,196 | $291 |
| Atorvastatin | 168 | $2,828 | $17 |
| Cymbalta | 12 | $2,702 | $225 |
| Ursodiol | 23 | $2,522 | $110 |
| Ventolin Hfa | 38 | $2,325 | $61 |
| Qvar | 12 | $2,236 | $186 |
| Alphagan P | 14 | $1,853 | $132 |
| Montelukast | 96 | $1,676 | $17 |
| Potassium Chloride | 50 | $1,436 | $29 |
| Hydrocodone-Acetaminophen | 67 | $1,436 | $21 |
| Tamsulosin | 55 | $1,414 | $26 |
| Metoprolol | 45 | $1,402 | $31 |
| Midodrine | 12 | $1,355 | $113 |
| Gabapentin | 41 | $1,353 | $33 |
| Losartan | 108 | $1,068 | $10 |
| Lidocaine-Prilocaine | 22 | $967 | $44 |
| Doxycycline Hyclate | 34 | $921 | $27 |
| Omeprazole | 66 | $867 | $13 |
| Ipratropium-Albuterol | 24 | $842 | $35 |
| Metformin | 98 | $828 | $8 |
| Allopurinol | 57 | $768 | $13 |
| Pravastatin | 24 | $763 | $32 |
| Donepezil | 63 | $755 | $12 |
| Lisinopril | 112 | $730 | $7 |
| Cefuroxime | 27 | $727 | $27 |
| Oxybutynin Chloride Er | 14 | $723 | $52 |
| Simvastatin | 74 | $702 | $9 |
| Clopidogrel | 35 | $694 | $20 |
| Amlodipine Besylate | 117 | $640 | $5 |
| Lovastatin | 35 | $591 | $17 |
| Lamotrigine | 15 | $533 | $36 |
| Sertraline | 71 | $516 | $7 |
| Fluticasone Propionate | 43 | $515 | $12 |
| Azelastine | 11 | $511 | $46 |
| Furosemide | 110 | $506 | $5 |
| Metoprolol | 61 | $505 | $8 |
| Verapamil Er | 16 | $475 | $30 |
| Finasteride | 25 | $448 | $18 |
| Prednisone | 46 | $434 | $9 |
| Famotidine | 31 | $404 | $13 |
| Carvedilol | 56 | $400 | $7 |
| Ranitidine | 13 | $368 | $28 |
| Alendronate | 47 | $367 | $8 |
| Zolpidem | 50 | $360 | $7 |
| Digoxin | 12 | $328 | $27 |
| Lorazepam | 36 | $300 | $8 |
| Fludrocortisone Acetate | 11 | $296 | $27 |
| Atenolol | 33 | $294 | $9 |
| Levetiracetam | 11 | $291 | $26 |
| Trazodone | 14 | $288 | $21 |
| Alprazolam | 45 | $275 | $6 |
| Mirtazapine | 15 | $273 | $18 |
| Escitalopram | 20 | $224 | $11 |
| Pantoprazole | 29 | $218 | $8 |
| Losartan-Hydrochlorothiazide | 13 | $216 | $17 |
| Levofloxacin | 16 | $192 | $12 |
| Triamterene-Hydrochlorothiazid | 17 | $189 | $11 |
| Klor-Con 10 | 17 | $173 | $10 |
| Isosorbide Mononitrate Er | 16 | $156 | $10 |
| Amitriptyline | 12 | $135 | $11 |
| Glipizide | 13 | $114 | $9 |
| Citalopram Hbr | 19 | $113 | $6 |
| Acetaminophen-Codeine | 11 | $106 | $10 |
| Tramadol | 20 | $104 | $5 |
| Lisinopril-Hydrochlorothiazide | 15 | $74 | $5 |
| Fluoxetine | 11 | $41 | $4 |
2015: 77 drugs
| Symbicort | 73 | $30,640 | $420 |
| Spiriva | 64 | $29,155 | $456 |
| Advair Diskus | 49 | $22,171 | $452 |
| Xarelto | 54 | $16,114 | $298 |
| Namenda Xr | 37 | $10,916 | $295 |
| Qvar | 42 | $9,401 | $224 |
| Sensipar | 12 | $7,397 | $616 |
| Combivent Respimat | 24 | $6,983 | $291 |
| Asmanex | 19 | $6,704 | $353 |
| Dulera | 22 | $6,240 | $284 |
| Atrovent Hfa | 15 | $6,211 | $414 |
| Spiriva Respimat | 16 | $5,670 | $354 |
| Budesonide | 23 | $5,566 | $242 |
| Benicar | 19 | $4,379 | $230 |
| Ursodiol | 22 | $4,345 | $197 |
| Proair Hfa | 73 | $4,318 | $59 |
| Azilect | 16 | $4,314 | $270 |
| Valsartan | 30 | $4,203 | $140 |
| Levemir | 14 | $3,972 | $284 |
| Lovaza | 11 | $3,250 | $295 |
| Levothyroxine | 110 | $2,637 | $24 |
| Atorvastatin | 124 | $2,206 | $18 |
| Metoprolol | 60 | $2,196 | $37 |
| Montelukast | 97 | $1,910 | $20 |
| Tamsulosin | 59 | $1,503 | $25 |
| Alphagan P | 12 | $1,460 | $122 |
| Ventolin Hfa | 17 | $1,337 | $79 |
| Doxycycline Hyclate | 32 | $1,273 | $40 |
| Gabapentin | 40 | $1,214 | $30 |
| Potassium Chloride | 41 | $1,157 | $28 |
| Cyclobenzaprine | 17 | $1,119 | $66 |
| Hydrocodone-Acetaminophen | 42 | $1,034 | $25 |
| Pravastatin | 29 | $934 | $32 |
| Lisinopril | 128 | $814 | $6 |
| Allopurinol | 58 | $798 | $14 |
| Metformin | 82 | $795 | $10 |
| Omeprazole | 67 | $759 | $11 |
| Losartan | 88 | $755 | $9 |
| Cefuroxime | 22 | $688 | $31 |
| Donepezil | 55 | $671 | $12 |
| Simvastatin | 68 | $617 | $9 |
| Furosemide | 124 | $596 | $5 |
| Bupropion Xl | 23 | $585 | $25 |
| Fluticasone Propionate | 46 | $572 | $12 |
| Sertraline | 74 | $556 | $8 |
| Amlodipine Besylate | 84 | $544 | $6 |
| Verapamil Er | 12 | $540 | $45 |
| Alendronate | 53 | $524 | $10 |
| Lamotrigine | 19 | $498 | $26 |
| Zolpidem | 35 | $457 | $13 |
| Ipratropium-Albuterol | 20 | $442 | $22 |
| Carvedilol | 60 | $428 | $7 |
| Lovastatin | 34 | $400 | $12 |
| Famotidine | 33 | $392 | $12 |
| Clopidogrel | 29 | $370 | $13 |
| Cartia Xt | 12 | $325 | $27 |
| Albuterol Sulfate | 17 | $319 | $19 |
| Levofloxacin | 24 | $306 | $13 |
| Metoprolol | 68 | $297 | $4 |
| Fluoxetine | 17 | $284 | $17 |
| Mirtazapine | 20 | $278 | $14 |
| Pantoprazole | 23 | $275 | $12 |
| Finasteride | 20 | $249 | $12 |
| Terazosin | 20 | $237 | $12 |
| Atenolol | 18 | $232 | $13 |
| Losartan-Hydrochlorothiazide | 15 | $190 | $13 |
| Alprazolam | 30 | $190 | $6 |
| Benazepril | 16 | $180 | $11 |
| Prednisone | 35 | $179 | $5 |
| Tramadol | 34 | $166 | $5 |
| Warfarin | 11 | $162 | $15 |
| Isosorbide Mononitrate Er | 11 | $125 | $11 |
| Spironolactone | 12 | $119 | $10 |
| Lisinopril-Hydrochlorothiazide | 15 | $86 | $6 |
| Lorazepam | 17 | $84 | $5 |
| Citalopram Hbr | 12 | $82 | $7 |
| Clonidine | 13 | $70 | $5 |
2014: 81 drugs
| Spiriva | 78 | $27,357 | $351 |
| Advair Diskus | 65 | $25,373 | $390 |
| Symbicort | 79 | $22,946 | $290 |
| Xarelto | 39 | $11,652 | $299 |
| Combivent Respimat | 33 | $9,143 | $277 |
| Asmanex | 29 | $8,585 | $296 |
| Crestor | 20 | $8,333 | $417 |
| Qvar | 38 | $7,540 | $198 |
| Sensipar | 13 | $7,135 | $549 |
| Atrovent Hfa | 17 | $6,413 | $377 |
| Diovan | 34 | $6,035 | $178 |
| Namenda Xr | 18 | $5,827 | $324 |
| Aggrenox | 11 | $4,045 | $368 |
| Budesonide | 15 | $3,955 | $264 |
| Benicar | 24 | $3,846 | $160 |
| Levemir | 14 | $3,315 | $237 |
| Tudorza Pressair | 11 | $3,275 | $298 |
| Proair Hfa | 57 | $3,119 | $55 |
| Nasonex | 18 | $3,071 | $171 |
| Avodart | 12 | $2,998 | $250 |
| Montelukast | 92 | $2,941 | $32 |
| Lovaza | 12 | $2,929 | $244 |
| Bystolic | 20 | $2,667 | $133 |
| Hydrocodone-Acetaminophen | 70 | $2,455 | $35 |
| Atorvastatin | 101 | $2,332 | $23 |
| Namenda | 13 | $2,159 | $166 |
| Valsartan | 14 | $1,989 | $142 |
| Metoprolol | 48 | $1,714 | $36 |
| Levothyroxine | 82 | $1,586 | $19 |
| Gabapentin | 42 | $1,377 | $33 |
| Novolin R | 12 | $1,328 | $111 |
| Potassium Chloride | 35 | $1,119 | $32 |
| Losartan | 68 | $1,090 | $16 |
| Cyclobenzaprine | 15 | $977 | $65 |
| Ventolin Hfa | 19 | $967 | $51 |
| Omeprazole | 74 | $948 | $13 |
| Pravastatin | 29 | $929 | $32 |
| Lisinopril | 116 | $860 | $7 |
| Tamsulosin | 50 | $832 | $17 |
| Amlodipine Besylate | 105 | $828 | $8 |
| Donepezil | 50 | $819 | $16 |
| Metformin | 57 | $801 | $14 |
| Doxycycline Hyclate | 12 | $783 | $65 |
| Sertraline | 84 | $777 | $9 |
| Venlafaxine Hcl Er | 17 | $537 | $32 |
| Furosemide | 111 | $513 | $5 |
| Lamotrigine | 19 | $513 | $27 |
| Lovastatin | 47 | $509 | $11 |
| Simvastatin | 56 | $497 | $9 |
| Fluticasone Propionate | 25 | $486 | $19 |
| Carvedilol | 62 | $442 | $7 |
| Allopurinol | 54 | $434 | $8 |
| Ipratropium-Albuterol | 17 | $425 | $25 |
| Alendronate | 33 | $407 | $12 |
| Losartan-Hydrochlorothiazide | 16 | $389 | $24 |
| Benazepril | 35 | $353 | $10 |
| Atenolol | 35 | $344 | $10 |
| Famotidine | 29 | $341 | $12 |
| Alprazolam | 42 | $333 | $8 |
| Pantoprazole | 33 | $327 | $10 |
| Diltiazem Er | 13 | $320 | $25 |
| Zolpidem | 32 | $304 | $10 |
| Bupropion Xl | 12 | $301 | $25 |
| Clopidogrel | 29 | $278 | $10 |
| Levofloxacin | 17 | $261 | $15 |
| Metoprolol | 34 | $260 | $8 |
| Finasteride | 18 | $259 | $14 |
| Terazosin | 15 | $246 | $16 |
| Warfarin | 19 | $243 | $13 |
| Prednisone | 31 | $217 | $7 |
| Klor-Con 10 | 12 | $179 | $15 |
| Mirtazapine | 15 | $179 | $12 |
| Spironolactone | 12 | $177 | $15 |
| Fluoxetine | 14 | $173 | $12 |
| Lorazepam | 15 | $111 | $7 |
| Paroxetine | 12 | $110 | $9 |
| Tramadol | 18 | $105 | $6 |
| Citalopram Hbr | 13 | $101 | $8 |
| Isosorbide Mononitrate Er | 11 | $94 | $9 |
| Clonidine | 16 | $91 | $6 |
| Lisinopril-Hydrochlorothiazide | 12 | $69 | $6 |
2013: 75 drugs
| Spiriva | 122 | $40,727 | $334 |
| Advair Diskus | 75 | $26,868 | $358 |
| Symbicort | 70 | $18,917 | $270 |
| Diovan | 43 | $8,800 | $205 |
| Qvar | 42 | $7,074 | $168 |
| Crestor | 12 | $5,706 | $476 |
| Benicar | 29 | $4,616 | $159 |
| Celebrex | 11 | $4,509 | $410 |
| Combivent | 16 | $4,440 | $277 |
| Combivent Respimat | 17 | $4,427 | $260 |
| Asmanex | 19 | $4,422 | $233 |
| Montelukast | 72 | $4,258 | $59 |
| Xarelto | 13 | $3,580 | $275 |
| Avodart | 17 | $3,408 | $200 |
| Flovent Hfa | 11 | $3,153 | $287 |
| Nasonex | 22 | $3,142 | $143 |
| Zolpidem Tartrate Er | 13 | $2,978 | $229 |
| Bystolic | 23 | $2,837 | $123 |
| Atorvastatin | 77 | $2,828 | $37 |
| Lovaza | 12 | $2,565 | $214 |
| Avelox | 12 | $2,181 | $182 |
| Proair Hfa | 40 | $2,034 | $51 |
| Metoprolol | 36 | $1,526 | $42 |
| Doxycycline Hyclate | 19 | $1,125 | $59 |
| Potassium Chloride | 46 | $1,089 | $24 |
| Metformin | 72 | $1,061 | $15 |
| Tamsulosin | 47 | $918 | $20 |
| Gabapentin | 24 | $913 | $38 |
| Sertraline | 95 | $909 | $10 |
| Hydrocodone-Acetaminophen | 70 | $904 | $13 |
| Levothyroxine | 47 | $823 | $18 |
| Omeprazole | 70 | $786 | $11 |
| Lisinopril | 102 | $784 | $8 |
| Donepezil | 34 | $780 | $23 |
| Amlodipine Besylate | 92 | $695 | $8 |
| Verapamil Er | 12 | $685 | $57 |
| Hydroxyzine | 20 | $650 | $33 |
| Clopidogrel | 20 | $640 | $32 |
| Losartan-Hydrochlorothiazide | 24 | $619 | $26 |
| Synthroid | 19 | $600 | $32 |
| Pravastatin | 32 | $577 | $18 |
| Warfarin | 50 | $544 | $11 |
| Diltiazem 24hr Er | 16 | $517 | $32 |
| Carvedilol | 46 | $506 | $11 |
| Simvastatin | 45 | $465 | $10 |
| Metoprolol | 49 | $463 | $9 |
| Paroxetine | 22 | $462 | $21 |
| Lovastatin | 30 | $462 | $15 |
| Venlafaxine Hcl Er | 11 | $458 | $42 |
| Alendronate | 34 | $443 | $13 |
| Atenolol | 43 | $442 | $10 |
| Losartan | 21 | $407 | $19 |
| Fluticasone Propionate | 11 | $383 | $35 |
| Furosemide | 88 | $371 | $4 |
| Klor-Con 10 | 19 | $351 | $18 |
| Sucralfate | 17 | $347 | $20 |
| Zolpidem | 36 | $288 | $8 |
| Pantoprazole | 12 | $288 | $24 |
| Benazepril | 27 | $262 | $10 |
| Acetaminophen-Codeine | 13 | $230 | $18 |
| Spironolactone | 12 | $222 | $19 |
| Alprazolam | 38 | $220 | $6 |
| Allopurinol | 22 | $219 | $10 |
| Diltiazem Er | 11 | $206 | $19 |
| Theophylline Anhydrous | 14 | $202 | $14 |
| Fluoxetine | 20 | $182 | $9 |
| Lorazepam | 23 | $179 | $8 |
| Prednisone | 57 | $179 | $3 |
| Cyclobenzaprine | 21 | $175 | $8 |
| Famotidine | 11 | $155 | $14 |
| Cephalexin | 12 | $116 | $10 |
| Clonidine | 17 | $99 | $6 |
| Mirtazapine | 16 | $95 | $6 |
| Dicyclomine | 11 | $46 | $4 |
| Ranitidine | 11 | $44 | $4 |
Money from drug and device companies
$80 in 2025
| 2025 | 2 | 4 | None | $80 |
| 2024 | 2 | 2 | None | $156 |
| 2022 | 4 | 7 | None | $772 |
| 2021 | 5 | 6 | None | $539 |
| 2020 | 2 | 2 | None | $258 |
| 2019 | 7 | 10 | None | $728 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Taltz | $65 | 3 payments
|
| Biofrontera | None | $15 | 1 payment
|
See all 4 published payments
| Lilly USA | Meals · 2025-06-12 | Taltz | $19 |
| Lilly USA | Meals · 2025-04-09 | Zepbound | $28 |
| Lilly USA | Meals · 2025-02-19 | Taltz | $18 |
| Biofrontera | Meals · 2025-02-05 | None | $15 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $156
| Boehringer Ingelheim Pharmaceuticals | None | $124 | 1 payment
|
| Boston Scientific | Acquire | $31 | 1 payment
|
2022: $772
| AstraZeneca Pharmaceuticals LP | Breztri | $350 | 3 payments
|
| Abbvie | Ubrelvy | $201 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $124 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $96 | 1 payment
|
2021: $539
| GlaxoSmithKline | Trelegy Ellipta | $157 | 2 payments
|
| Amgen | None | $125 | 1 payment
|
| Acerta Pharma | None | $125 | 1 payment
|
| Medtronic | Endurant | $116 | 1 payment
|
| OptiNose US | Xhance | $15 | 1 payment
|
2020: $258
| Teva Pharmaceuticals USA | Ajovy | $133 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $125 | 1 payment
|
2019: $728
| Boehringer Ingelheim Pharmaceuticals | Ofev | $242 | 3 payments
|
| Abbott Laboratories | Merlin Connectivity and Remote | $216 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $125 | 1 payment
|
| Pfizer | Eliquis | $89 | 1 payment
|
| Boston Scientific | Emblem | $28 | 1 payment
|
| Roche Diagnostics | Cd Cobas Reagents | $15 | 1 payment
|
| Merck Sharp & Dohme | Zerbaxa | $13 | 1 payment
|
Professional record
- NPI
- 1245230333
- Licence
- CA A73871California A73871: Current · expires 2028-05-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A738710
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RS0012X (207RS0012X)
- Mailing address
- 1133 E Stanley Blvd Ste 101, Livermore, CA, 94550
- NPI first listed
- 2005-07-29
- NPI last updated
- 2024-04-25
- NPI record certified
- 2024-04-25
This is when the NPI record was last certified, not a medical board exam.